Connect Biopharma Holdings Ltd Adr (CNTB)

Aug 14, 2025

Connect Biopharma Posts Q2 Revenue Drop - AOL.com

Aug 14, 2025

Aug 14, 2025

Connect Biopharma Reports Q2 Revenue Drop of 99.2% to $48,000, R&D Spending Increases 65.6% to $8.8mln - AInvest

Aug 14, 2025

Aug 13, 2025

Connect Biopharma Posts Q2 Revenue Drop - The Motley Fool

Aug 13, 2025

Aug 13, 2025

Connect Biopharma Holdings Ltd SEC 10-Q Report - TradingView

Aug 13, 2025

Aug 13, 2025

Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

Aug 13, 2025

Aug 06, 2025

Connect Biopharma Holdings Limited shares rise 5.63% after-hours following Jazz Pharmaceuticals' FDA approval of Modeyso. - AInvest

Aug 06, 2025

Aug 01, 2025

Connect Biopharma Shares Rise on Plan to End ADR Program and Directly List on Nasdaq - MSN

Aug 01, 2025

Jul 30, 2025

What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Jul 30, 2025

Jul 27, 2025

Research Analysts Set Expectations for CNTB Q2 Earnings - MarketBeat

Jul 27, 2025

Jul 25, 2025

Connect Biopharma (NASDAQ:CNTB) Upgraded at Northland Capmk - Defense World

Jul 25, 2025

Jul 25, 2025

Q2 Earnings Estimate for CNTB Issued By Northland Capmk - Defense World

Jul 25, 2025

Jul 22, 2025

Connect Biopharma stock rating reiterated as Outperform by Northland - Investing.com Australia

Jul 22, 2025

Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Connect Biopharma appoints Jim Schoeneck to board of directors - Investing.com Australia

Jul 22, 2025

Jul 22, 2025

Connect Biopharma appoints James A. Schoeneck to board of directors By Investing.com - Investing.com Nigeria

Jul 22, 2025

Jul 22, 2025

Northland starts Connect Biopharma at Outperform on chance to define new class - TipRanks

Jul 22, 2025

Jul 21, 2025

Connect Biopharma stock rises after announcing plan to terminate ADR program - Investing.com

Jul 21, 2025

Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares By Investing.com - Investing.com India

Jul 21, 2025

Jul 21, 2025

Connect Biopharma to terminate ADR program, list ordinary shares - Investing.com

Jul 21, 2025

Jul 21, 2025

Connect Biopharma to Terminate ADR Program and List Ordinary Shares on Nasdaq - Nasdaq

Jul 21, 2025

Jul 21, 2025

Connect Biopharma Announces Plans to Terminate its American - GlobeNewswire

Jul 21, 2025

Jul 21, 2025

Connect Biopharma Streamlines Trading: ADRs Convert to Direct Nasdaq Shares in Major US Market Push - Stock Titan

Jul 21, 2025

Jul 21, 2025

Connect Biopharma Terminates ADS Agreement with Deutsche Bank - AInvest

Jul 21, 2025

Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with minimum bid price rule - Investing.com India

Jul 17, 2025

Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with minimum bid price rule By Investing.com - Investing.com South Africa

Jul 17, 2025

Jul 17, 2025

Connect Biopharma regains Nasdaq compliance with $1 minimum bid price - Investing.com

Jul 17, 2025

Jul 11, 2025

Connect Biopharma Holdings shares rise 7.89% in after-hours after partner's new drug application for atopic dermatitis is accepted by NMPA. - AInvest

Jul 11, 2025

Jul 09, 2025

Connect Biopharma’s partner submits new drug application in China - Investing.com

Jul 09, 2025

Jul 09, 2025

Connect Biopharma’s partner submits new drug application in China By Investing.com - Investing.com South Africa

Jul 09, 2025

Jul 08, 2025

Connect Biopharma (NASDAQ:CNTB) Trading Down 2.5% – Here’s What Happened - Defense World

Jul 08, 2025

Jun 13, 2025

Connect Biopharma reports positive data for asthma treatment By Investing.com - Investing.com South Africa

Jun 13, 2025

Jun 13, 2025

Connect Biopharma reports positive data for asthma treatment - Investing.com

Jun 13, 2025

May 13, 2025

Connect Biopharma begins Phase 2 asthma study - Investing.com

May 13, 2025

Apr 04, 2025

Connect Biopharma stock hits 52-week low at $0.55 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

Connect Biopharma stock hits 52-week low at $0.55 amid market challenges - Investing.com

Apr 04, 2025

Apr 01, 2025

FDA greenlights Connect Biopharma’s asthma and COPD trials - Investing.com

Apr 01, 2025

Apr 01, 2025

Connect Biopharma stock holds $8 target, Buy rating at H.C. Wainwright - Investing.com

Apr 01, 2025

Apr 01, 2025

Connect Biopharma shares rise 1.62% after-hours following positive FDA feedback on Phase 2 trials for asthma and COPD treatments. - AInvest

Apr 01, 2025

Mar 29, 2025

Connect Biopharma faces Nasdaq delisting over share price By Investing.com - Investing.com India

Mar 29, 2025

Mar 28, 2025

Connect Biopharma faces Nasdaq delisting over share price - Investing.com

Mar 28, 2025

Mar 27, 2025

Connect Biopharma stock hits 52-week low at $0.76 - Investing.com

Mar 27, 2025

Feb 18, 2025

Connect Biopharma stock hits 52-week low at $0.91 amid market challenges - Investing.com India

Feb 18, 2025

Jan 22, 2025

Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com

Jan 22, 2025

Dec 18, 2024

Top 3 Aerospace and Defense Stocks Flying Under the Radar - The Globe and Mail

Dec 18, 2024

Nov 28, 2023

Is Connect Biopharma Holdings (CNTB) Stock Outpacing Its Medical Peers This Year? - Nasdaq

Nov 28, 2023

Mar 20, 2023

Stocks Set to Open Lower as Investors Await Fed Meeting, Banking Sector Remains in Focus - Barchart.com

Mar 20, 2023